首页 > 最新文献

北京大学学报(医学版)最新文献

英文 中文
[Ferroptosis-related long non-coding RNA to predict the clinical outcome of non-small cell lung cancer after radiotherapy]. [凋亡相关长链非编码RNA预测非小细胞肺癌放疗后临床转归]。
Q3 Medicine Pub Date : 2025-06-18
Q Xu, T Liu, J Wang
<p><strong>Objective: </strong>To construct a long non-coding RNA (lncRNA) model based on ferroptosis and predict the prognosis of non-small cell lung cancer (NSCLC) patients after radiotherapy, to develop a comprehensive framework that integrates genomic data with clinical outcomes, and to identify lncRNA associated with ferroptosis and evaluate their predictive power for patient survival and progression-free survival following radiotherapy.</p><p><strong>Methods: </strong>This study commenced by acquiring standardized transcriptome data from primary tumors and normal tissues, along with corresponding clinical information, from the cancer genome atlas (TCGA) database. This dataset provided a robust foundation for identifying differentially expressed genes (DEGs) related to ferroptosis. These analyses helped pinpoint specific pathways and biological processes involved in ferroptosis, such as glutathione metabolism, lipid signaling, oxidative stress, and reactive oxygen species (ROS) metabolism. Subsequently, univariate and multivariate Cox regression analyses were conducted to construct a predictive model based on lncRNA associated with ferroptosis. The goal was to differentiate between the high-risk and low-risk groups of NSCLC patients who had undergone radiotherapy. By incorporating these lncRNA into the model, we aimed to provide a more accurate prediction of patient outcomes. The performance of the model was validated by comparing the survival rates and progression-free survival between the high-risk and low-risk groups. Additionally, differences in gene expression patterns and pathway activities between these two groups were examined to further validate the model's effectiveness.</p><p><strong>Results: </strong>Our analysis revealed that the differentially expressed genes related to ferroptosis were significantly enriched in several key pathways, including ferroptosis itself, glutathione metabolism, lipid signaling, and processes involving oxidative stress and ROS metabolism. Based on these findings, we constructed a prognostic model using 14 lncRNA that showed strong associations with ferroptosis. Further data analysis demonstrated that these lncRNA could independently predict the prognosis of NSCLC patients after radiotherapy. Specifically, age, stage, and gender were used as clinical pathological variables, and the results indicated that the high-risk group of NSCLC patients had a poorer prognosis following radiotherapy. This finding underscores the potential of the model to serve as a valuable tool for predicting prognosis for NSCLC patients undergoing radiotherapy.</p><p><strong>Conclusion: </strong>The risk model developed in this study can independently predict the prognosis of NSCLC patients after radiotherapy. This model provides a solid basis for understanding the role of ferroptosis-related lncRNA in the prognosis of NSCLC patients following radiotherapy. Furthermore, it offers clinical guidance for combining radiotherapy with fe
目的:构建基于铁ptosis的长链非编码RNA (lncRNA)模型,预测非小细胞肺癌(NSCLC)患者放疗后预后,建立整合基因组数据与临床结果的综合框架,鉴定与铁ptosis相关的lncRNA,并评估其对放疗后患者生存和无进展生存的预测能力。方法:本研究首先从癌症基因组图谱(TCGA)数据库中获取原发肿瘤和正常组织的标准化转录组数据,以及相应的临床信息。该数据集为鉴定与铁下垂相关的差异表达基因(DEGs)提供了坚实的基础。这些分析有助于查明与铁下垂有关的特定途径和生物学过程,如谷胱甘肽代谢、脂质信号、氧化应激和活性氧(ROS)代谢。随后,进行单因素和多因素Cox回归分析,构建基于lncRNA与铁下垂相关的预测模型。目的是区分接受放疗的NSCLC患者的高危组和低危组。通过将这些lncRNA纳入模型,我们旨在提供更准确的患者预后预测。通过比较高危组和低危组的生存率和无进展生存期来验证模型的性能。此外,我们还检测了两组之间基因表达模式和途径活性的差异,以进一步验证模型的有效性。结果:我们的分析显示,与铁下垂相关的差异表达基因在几个关键途径中显著富集,包括铁下垂本身、谷胱甘肽代谢、脂质信号传导以及涉及氧化应激和ROS代谢的过程。基于这些发现,我们使用14个与铁下垂密切相关的lncRNA构建了预后模型。进一步的数据分析表明,这些lncRNA能够独立预测NSCLC患者放疗后的预后。具体以年龄、分期、性别作为临床病理变量,结果显示高危组NSCLC患者放疗后预后较差。这一发现强调了该模型作为预测非小细胞肺癌放疗患者预后的有价值工具的潜力。结论:本研究建立的风险模型能够独立预测NSCLC患者放疗后的预后。该模型为了解嗜铁相关lncRNA在NSCLC患者放疗后预后中的作用提供了坚实的基础。此外,它为放射治疗与铁中毒靶向治疗相结合提供了临床指导,有可能改善NSCLC患者的治疗效果。本研究中基因组和临床数据的整合突出了肿瘤个性化医疗方法的重要性,为更精确和有效的治疗策略铺平了道路。
{"title":"[Ferroptosis-related long non-coding RNA to predict the clinical outcome of non-small cell lung cancer after radiotherapy].","authors":"Q Xu, T Liu, J Wang","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To construct a long non-coding RNA (lncRNA) model based on ferroptosis and predict the prognosis of non-small cell lung cancer (NSCLC) patients after radiotherapy, to develop a comprehensive framework that integrates genomic data with clinical outcomes, and to identify lncRNA associated with ferroptosis and evaluate their predictive power for patient survival and progression-free survival following radiotherapy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This study commenced by acquiring standardized transcriptome data from primary tumors and normal tissues, along with corresponding clinical information, from the cancer genome atlas (TCGA) database. This dataset provided a robust foundation for identifying differentially expressed genes (DEGs) related to ferroptosis. These analyses helped pinpoint specific pathways and biological processes involved in ferroptosis, such as glutathione metabolism, lipid signaling, oxidative stress, and reactive oxygen species (ROS) metabolism. Subsequently, univariate and multivariate Cox regression analyses were conducted to construct a predictive model based on lncRNA associated with ferroptosis. The goal was to differentiate between the high-risk and low-risk groups of NSCLC patients who had undergone radiotherapy. By incorporating these lncRNA into the model, we aimed to provide a more accurate prediction of patient outcomes. The performance of the model was validated by comparing the survival rates and progression-free survival between the high-risk and low-risk groups. Additionally, differences in gene expression patterns and pathway activities between these two groups were examined to further validate the model's effectiveness.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Our analysis revealed that the differentially expressed genes related to ferroptosis were significantly enriched in several key pathways, including ferroptosis itself, glutathione metabolism, lipid signaling, and processes involving oxidative stress and ROS metabolism. Based on these findings, we constructed a prognostic model using 14 lncRNA that showed strong associations with ferroptosis. Further data analysis demonstrated that these lncRNA could independently predict the prognosis of NSCLC patients after radiotherapy. Specifically, age, stage, and gender were used as clinical pathological variables, and the results indicated that the high-risk group of NSCLC patients had a poorer prognosis following radiotherapy. This finding underscores the potential of the model to serve as a valuable tool for predicting prognosis for NSCLC patients undergoing radiotherapy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The risk model developed in this study can independently predict the prognosis of NSCLC patients after radiotherapy. This model provides a solid basis for understanding the role of ferroptosis-related lncRNA in the prognosis of NSCLC patients following radiotherapy. Furthermore, it offers clinical guidance for combining radiotherapy with fe","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"569-577"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes]. [代谢功能障碍相关脂肪变性肝病和心脏代谢危险因素异常与不良妊娠结局的关系]。
Q3 Medicine Pub Date : 2025-06-18
S Yang, Y Li, H Cui, Y Wang, Y Wu, M Wang, Y Yang, N Enkar, L Yang, H Wang
<p><strong>Objective: </strong>To investigate the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and the risk of adverse pregnancy outcomes, and to analyze the impact of the type and severity of cardiometabolic risk factor (CMRF) abnormalities on this association.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted among primiparous women with singleton pregnancies who had registered at Beijing Friendship Hospital from March 10, 2020, to December 31, 2022. A total of 2 623 women were included. Basic characteristics and delivery outcomes were documented, liver ultrasound and relevant prenatal examinations were performed, and adverse pregnancy outcomes were diagnosed. Modified Poisson regression models were used to analyze the association between MASLD and adverse pregnancy outcomes. The relationship between the type or severity of CMRF abnormalities in MASLD and the risk of adverse pregnancy outcomes was also explored.</p><p><strong>Results: </strong>After adjusting for confounding factors including age, gestational weight gain, and education level, MASLD was associated with an increased risk of cesarean section (<i>RR</i>=1.531, 95%<i>CI</i>: 1.304-1.799, <i>P</i> < 0.001), gestational diabetes mellitus (GDM; <i>RR</i>=2.409, 95%<i>CI</i>: 1.948-2.979, <i>P</i> < 0.001), pregnancy-associated hypertension (PAH; <i>RR</i>=3.062, 95%<i>CI</i>: 2.069-4.533, <i>P</i> < 0.001), preterm birth (<i>RR</i>=2.145, 95%<i>CI</i>: 1.342-3.429, <i>P</i>=0.001), and large for gestational age (LGA; 2.224, 95%<i>CI</i>: 1.599-3.095, <i>P</i> < 0.001). However, no significant associations were found for small for gestational age or postpartum hemorrhage. After adjusting for other CMRF abnormalities, the risk of adverse pregnancy outcomes varied among MASLD pregnant women with different CMRF abnormalities: the body mass index abnormal group had higher risks of cesarean section, GDM, PAH, preterm birth, and LGA; the glucose abnormal group had an increased risk of GDM; the blood pressure abnormal group had a higher risk of PAH; the high density lipoprotein cholesterol abnormal group had higher risks of cesarean section, GDM, and PAH; and the triglyceride abnormal group was associated with higher risks of GDM and preterm birth. Additional, as the severity of CMRF abnormalities increased, the risks of cesarean section (<i>RR</i>=1.199, 95%<i>CI</i>: 1.112-1.292, <i>P</i> < 0.001), GDM (<i>RR</i>=1.478, 95%<i>CI</i>: 1.345-1.624, <i>P</i> < 0.001), PAH (<i>RR</i>=1.626, 95%<i>CI</i>: 1.367-1.934, <i>P</i> < 0.001), preterm birth (<i>RR</i>=1.384, 95%<i>CI</i>: 1.120-1.710, <i>P</i>=0.003), and LGA (<i>RR</i>=1.422, 95%<i>CI</i>: 1.224-1.650, <i>P</i> < 0.001) continued to rise.</p><p><strong>Conclusion: </strong>MASLD during pregnancy is associated with an increased risk of multiple adverse pregnancy outcomes, and the type and severity of CMRF abnormalities significantly influence this association. These result
目的:探讨代谢功能障碍相关脂肪变性肝病(MASLD)与妊娠不良结局风险的相关性,并分析心脏代谢危险因素(CMRF)异常类型和严重程度对这一相关性的影响。方法:对2020年3月10日至2022年12月31日在北京友谊医院就诊的单胎妊娠初产妇进行回顾性队列研究。共包括2 623名妇女。记录基本特征和分娩结局,进行肝脏超声及相关产前检查,诊断不良妊娠结局。采用修正泊松回归模型分析MASLD与不良妊娠结局的关系。还探讨了MASLD中CMRF异常的类型或严重程度与不良妊娠结局风险之间的关系。结果:在校正了年龄、妊娠期体重增加、受教育程度等混杂因素后,MASLD与剖宫产(RR=1.531, 95%CI: 1.304 ~ 1.799, P < 0.001)、妊娠期糖尿病(GDM;RR=2.409, 95%CI: 1.948 ~ 2.979, P < 0.001),妊娠相关性高血压(PAH;RR=3.062, 95%CI: 2.069 ~ 4.533, P < 0.001)、早产(RR=2.145, 95%CI: 1.342 ~ 3.429, P=0.001)、胎龄大(LGA;2.224, 95%ci: 1.599 ~ 3.095, p < 0.001)。然而,没有发现胎龄小或产后出血的显著关联。在校正其他CMRF异常后,不同CMRF异常的MASLD孕妇发生不良妊娠结局的风险存在差异:体重指数异常组发生剖宫产、GDM、PAH、早产和LGA的风险较高;血糖异常组发生GDM的风险增加;血压异常组发生PAH的风险较高;高密度脂蛋白胆固醇异常组剖宫产、GDM、PAH风险较高;甘油三酯异常组与GDM和早产风险较高相关。此外,随着CMRF异常严重程度的增加,剖宫产(RR=1.199, 95%CI: 1.112 ~ 1.292, P < 0.001)、GDM (RR=1.478, 95%CI: 1.345 ~ 1.624, P < 0.001)、PAH (RR=1.626, 95%CI: 1.367 ~ 1.934, P < 0.001)、早产(RR=1.384, 95%CI: 1.120 ~ 1.710, P=0.003)、LGA (RR=1.422, 95%CI: 1.224 ~ 1.650, P < 0.001)的风险持续上升。结论:妊娠期MASLD与多种不良妊娠结局的风险增加相关,CMRF异常的类型和严重程度显著影响这种关联。这些结果提示,在诊断MASLD时应注意特定的CMRF异常,因为这可能有助于进行有针对性的干预,降低不良妊娠结局的风险。
{"title":"[Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes].","authors":"S Yang, Y Li, H Cui, Y Wang, Y Wu, M Wang, Y Yang, N Enkar, L Yang, H Wang","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and the risk of adverse pregnancy outcomes, and to analyze the impact of the type and severity of cardiometabolic risk factor (CMRF) abnormalities on this association.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective cohort study was conducted among primiparous women with singleton pregnancies who had registered at Beijing Friendship Hospital from March 10, 2020, to December 31, 2022. A total of 2 623 women were included. Basic characteristics and delivery outcomes were documented, liver ultrasound and relevant prenatal examinations were performed, and adverse pregnancy outcomes were diagnosed. Modified Poisson regression models were used to analyze the association between MASLD and adverse pregnancy outcomes. The relationship between the type or severity of CMRF abnormalities in MASLD and the risk of adverse pregnancy outcomes was also explored.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;After adjusting for confounding factors including age, gestational weight gain, and education level, MASLD was associated with an increased risk of cesarean section (&lt;i&gt;RR&lt;/i&gt;=1.531, 95%&lt;i&gt;CI&lt;/i&gt;: 1.304-1.799, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), gestational diabetes mellitus (GDM; &lt;i&gt;RR&lt;/i&gt;=2.409, 95%&lt;i&gt;CI&lt;/i&gt;: 1.948-2.979, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), pregnancy-associated hypertension (PAH; &lt;i&gt;RR&lt;/i&gt;=3.062, 95%&lt;i&gt;CI&lt;/i&gt;: 2.069-4.533, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), preterm birth (&lt;i&gt;RR&lt;/i&gt;=2.145, 95%&lt;i&gt;CI&lt;/i&gt;: 1.342-3.429, &lt;i&gt;P&lt;/i&gt;=0.001), and large for gestational age (LGA; 2.224, 95%&lt;i&gt;CI&lt;/i&gt;: 1.599-3.095, &lt;i&gt;P&lt;/i&gt; &lt; 0.001). However, no significant associations were found for small for gestational age or postpartum hemorrhage. After adjusting for other CMRF abnormalities, the risk of adverse pregnancy outcomes varied among MASLD pregnant women with different CMRF abnormalities: the body mass index abnormal group had higher risks of cesarean section, GDM, PAH, preterm birth, and LGA; the glucose abnormal group had an increased risk of GDM; the blood pressure abnormal group had a higher risk of PAH; the high density lipoprotein cholesterol abnormal group had higher risks of cesarean section, GDM, and PAH; and the triglyceride abnormal group was associated with higher risks of GDM and preterm birth. Additional, as the severity of CMRF abnormalities increased, the risks of cesarean section (&lt;i&gt;RR&lt;/i&gt;=1.199, 95%&lt;i&gt;CI&lt;/i&gt;: 1.112-1.292, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), GDM (&lt;i&gt;RR&lt;/i&gt;=1.478, 95%&lt;i&gt;CI&lt;/i&gt;: 1.345-1.624, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), PAH (&lt;i&gt;RR&lt;/i&gt;=1.626, 95%&lt;i&gt;CI&lt;/i&gt;: 1.367-1.934, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), preterm birth (&lt;i&gt;RR&lt;/i&gt;=1.384, 95%&lt;i&gt;CI&lt;/i&gt;: 1.120-1.710, &lt;i&gt;P&lt;/i&gt;=0.003), and LGA (&lt;i&gt;RR&lt;/i&gt;=1.422, 95%&lt;i&gt;CI&lt;/i&gt;: 1.224-1.650, &lt;i&gt;P&lt;/i&gt; &lt; 0.001) continued to rise.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;MASLD during pregnancy is associated with an increased risk of multiple adverse pregnancy outcomes, and the type and severity of CMRF abnormalities significantly influence this association. These result","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"487-495"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021]. [1990 - 2021年中国及全球年龄相关性听力损失的疾病负担及未来趋势预测]。
Q3 Medicine Pub Date : 2025-06-18
A Anargul, Y Song, X Yan, Y Gao, B Liu, G Hu
<p><strong>Objective: </strong>To describe the trend of changes in the disease burden of age-related hearing loss in China and globally from 1990 to 2021, to forecast the prevalence and years lived with disability (YLD) rates of age-related hearing loss from 2022 to 2036, and to provide a reference for the prevention and control of the disease burden associated with age-related hearing loss.</p><p><strong>Methods: </strong>Using the Global Burden of Disease 2021 (GBD2021) data, this study selected age-standardized prevalence rate (ASPR) and YLD as indicators. The disease burden and long-term trends of age-related hearing loss in China and globally from 1990 to 2021 were described by different socio-demographic index (SDI) and gender. Joinpoint regression was used to calculate the average annual percent change (AAPC) to assess the trend changes in the disease burden. Decomposition analysis was applied to explore the relative impacts of aging, population growth, and epidemiological changes on the variation in disease burden. An autoregressive integrated moving average (ARIMA) model was used to forecast the age-standardized pre-valence rate and YLD rates from 2022 to 2036.</p><p><strong>Results: </strong>The prevalence of age-related hearing loss in China in 2021 was 82 162.49 (73 288.08-89 187.21) per 100 000, higher than the global SDI level of 66 238.16 (59 982.54-72 669.82) per 100 000, the high SDI region ' s level of 57 650.42 (52 059.12-63 889.02) per 100 000, the upper-middle SDI region ' s level of 69 115.59 (62 494.18- 75 340.64) per 100 000, the middle SDI region ' s level of 72 365.56 (65 181.43-78 912.01) per 100 000, the lower-middle SDI region ' s level of 64 439.66 (58 368.22-71 468.27) per 100 000, and the low SDI region ' s level of 61 725.25 (55 749.18-68 477.67) per 100 000. The age- related hearing loss YLD rate in China was 2 762.98 [95% uncertainty interval (<i>UI</i>): 1 855.28-3 880.68] per 100 000, higher than the global SDI level of 2 236.75 (95%<i>UI</i>: 1 511.56-3 155.88) per 100 000, the high SDI region ' s level of 1 805.79 (95%<i>UI</i>: 1 212.69-2 577.17) per 100 000, the upper-middle SDI region ' s level of 2 316.58 (95%<i>UI</i>: 1 557.53-3 274.87) per 100 000, the middle SDI region ' s level of 2 480.99 (95%<i>UI</i>: 1 678.17-3 489.24) per 100 000, the lower-middle SDI region ' s level of 2 313.28 (95%<i>UI</i>: 1 578.35-3 271.50) per 100 000, and the low SDI region ' s level of 2 383.55 (95%<i>UI</i>: 1 623.66-3 365.68) per 100 000. From 1990 to 2021, both the prevalence and YLD rate of age-related hearing loss in China showed an increasing trend, rising by an average of 0.18% (95%<i>CI</i>: 0.16%-0.19%) and 0.29% (95%<i>CI</i>: 0.27%-0.30%) per year, respectively. The rates of increase in prevalence were the same for both men and women, with men showing a 0.18% increase (95%<i>CI</i>: 0.17%-0.19%, <i>P</i> < 0.001) and women showing a 0.18% increase (95%<i>CI</i>: 0.16%-0.19%, <i>P</i> < 0.001). However, the Y
目的:描述1990 - 2021年中国及全球年龄相关性听力损失疾病负担变化趋势,预测2022 - 2036年年龄相关性听力损失患病率和残疾年(YLD)率,为预防和控制年龄相关性听力损失疾病负担提供参考。方法:采用全球疾病负担2021 (GBD2021)数据,选择年龄标准化患病率(ASPR)和YLD作为指标。用不同的社会人口指数(SDI)和性别描述了1990年至2021年中国和全球年龄相关性听力损失的疾病负担和长期趋势。采用关节点回归计算平均年变化百分比(AAPC),评估疾病负担的趋势变化。采用分解分析探讨老龄化、人口增长和流行病学变化对疾病负担变化的相对影响。采用自回归综合移动平均(ARIMA)模型预测2022 - 2036年年龄标准化前价率和YLD率。结果:2021年在中国的患病率与年龄相关的听力损失是82 162.49(每100 000 73 288.08 -89 187.21),高于66年的全球SDI级别每100 000 238.16 982.54 -72 669.82(59),高SDI地区的年代57 650.42每100 000(52 059.12 -63 889.02),中上SDI地区的水平69 115.59(每100 000 62 494.18 - 75 340.64),中间SDI地区的水平72 365.56(每100 000 65 181.43 -78 912.01),中下SDI区为64 439.66(58 368.22 ~ 71 468.27)/ 10万,低SDI区为61 725.25(55 749.18 ~ 68 477.67)/ 10万。年龄相关听力损失在中国收获率率2 762.98(95%不确定性区间(UI): 1 880.68 855.28 - 3]每100人000人,高于全球SDI 2水平236.75 155.88 (95% UI: 1 511.56 - 3) 100 000,高SDI地区的s水平1 805.79 577.17 (95% UI: 1 - 212.69 2) 100 000,中上SDI地区的s水平2 316.58 274.87 (95% UI: 1 557.53 - 3) 100 000,中间SDI地区的水平2 480.99(95%用户界面:1 678.17 ~ 3 489.24) / 10万,中下地区为2 313.28 (95%UI: 1 578.35 ~ 3 271.50) / 10万,低地区为2 383.55 (95%UI: 1 623.66 ~ 3 365.68) / 10万。1990 - 2021年,中国年龄相关性听力损失患病率和YLD率均呈上升趋势,年均上升0.18% (95%CI: 0.16%-0.19%),年均上升0.29% (95%CI: 0.27%-0.30%)。男性和女性的患病率增加率相同,男性增加0.18% (95%CI: 0.17%-0.19%, P < 0.001),女性增加0.18% (95%CI: 0.16%-0.19%, P < 0.001)。然而,男性的YLD增加速度比女性快,男性增加0.32% (95%CI: 0.27%-0.37%, P < 0.001),女性增加0.27% (95%CI: 0.26%-0.28%, P < 0.001)。分解分析表明,人口增长是推动全球和不同SDI区域患病率和YLD率上升的主要因素。然而,在中国,老龄化是导致患病率和YLD率上升的主要因素。ARIMA模型预测,2022 - 2036年,年龄相关性听力损失患病率和YLD率将持续上升,2036年预测患病率和YLD率分别达到89 723.99 / 10万和2 872.47 / 10万。结论:中国60岁及以上人群年龄相关性听力损失患病率和疾病负担居全球首位。从1990年到2021年,年龄相关性听力损失的患病率和YLD率均呈现持续上升趋势,持续超过全球各SDI地区的水平。年龄相关性听力损失的患病率和疾病负担在老年男性中尤为显著。此外,预测表明,与年龄有关的听力损失的疾病负担将在未来15年内继续上升。因此,迫切需要密切关注这一特定人群的年龄相关性听力损失,早期干预措施对于减少年龄相关性听力损失相关的疾病负担至关重要。
{"title":"[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].","authors":"A Anargul, Y Song, X Yan, Y Gao, B Liu, G Hu","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To describe the trend of changes in the disease burden of age-related hearing loss in China and globally from 1990 to 2021, to forecast the prevalence and years lived with disability (YLD) rates of age-related hearing loss from 2022 to 2036, and to provide a reference for the prevention and control of the disease burden associated with age-related hearing loss.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Using the Global Burden of Disease 2021 (GBD2021) data, this study selected age-standardized prevalence rate (ASPR) and YLD as indicators. The disease burden and long-term trends of age-related hearing loss in China and globally from 1990 to 2021 were described by different socio-demographic index (SDI) and gender. Joinpoint regression was used to calculate the average annual percent change (AAPC) to assess the trend changes in the disease burden. Decomposition analysis was applied to explore the relative impacts of aging, population growth, and epidemiological changes on the variation in disease burden. An autoregressive integrated moving average (ARIMA) model was used to forecast the age-standardized pre-valence rate and YLD rates from 2022 to 2036.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The prevalence of age-related hearing loss in China in 2021 was 82 162.49 (73 288.08-89 187.21) per 100 000, higher than the global SDI level of 66 238.16 (59 982.54-72 669.82) per 100 000, the high SDI region ' s level of 57 650.42 (52 059.12-63 889.02) per 100 000, the upper-middle SDI region ' s level of 69 115.59 (62 494.18- 75 340.64) per 100 000, the middle SDI region ' s level of 72 365.56 (65 181.43-78 912.01) per 100 000, the lower-middle SDI region ' s level of 64 439.66 (58 368.22-71 468.27) per 100 000, and the low SDI region ' s level of 61 725.25 (55 749.18-68 477.67) per 100 000. The age- related hearing loss YLD rate in China was 2 762.98 [95% uncertainty interval (&lt;i&gt;UI&lt;/i&gt;): 1 855.28-3 880.68] per 100 000, higher than the global SDI level of 2 236.75 (95%&lt;i&gt;UI&lt;/i&gt;: 1 511.56-3 155.88) per 100 000, the high SDI region ' s level of 1 805.79 (95%&lt;i&gt;UI&lt;/i&gt;: 1 212.69-2 577.17) per 100 000, the upper-middle SDI region ' s level of 2 316.58 (95%&lt;i&gt;UI&lt;/i&gt;: 1 557.53-3 274.87) per 100 000, the middle SDI region ' s level of 2 480.99 (95%&lt;i&gt;UI&lt;/i&gt;: 1 678.17-3 489.24) per 100 000, the lower-middle SDI region ' s level of 2 313.28 (95%&lt;i&gt;UI&lt;/i&gt;: 1 578.35-3 271.50) per 100 000, and the low SDI region ' s level of 2 383.55 (95%&lt;i&gt;UI&lt;/i&gt;: 1 623.66-3 365.68) per 100 000. From 1990 to 2021, both the prevalence and YLD rate of age-related hearing loss in China showed an increasing trend, rising by an average of 0.18% (95%&lt;i&gt;CI&lt;/i&gt;: 0.16%-0.19%) and 0.29% (95%&lt;i&gt;CI&lt;/i&gt;: 0.27%-0.30%) per year, respectively. The rates of increase in prevalence were the same for both men and women, with men showing a 0.18% increase (95%&lt;i&gt;CI&lt;/i&gt;: 0.17%-0.19%, &lt;i&gt;P&lt;/i&gt; &lt; 0.001) and women showing a 0.18% increase (95%&lt;i&gt;CI&lt;/i&gt;: 0.16%-0.19%, &lt;i&gt;P&lt;/i&gt; &lt; 0.001). However, the Y","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"545-553"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological characteristics of myopia and pre-myopia among preschool children aged 5-6 years in ten provinces of China]. [中国10省5 ~ 6岁学龄前儿童近视及准近视流行病学特征]。
Q3 Medicine Pub Date : 2025-06-18
M Tang, Y Liu, R Qin, X Guo, H Li

Objective: To describe the prevalence of myopia and pre-myopia among preschool children aged 5-6 years in ten provinces or municipalities (hereinafter referred to as province) of China, and to provide a reference for the prevention and control of myopia, and the allocation of related health resources.

Methods: Convenience sampling was used to select preschool children aged 5-6 years from 21 cities in 10 provinces (including 8 provinces and 2 municipalities) in China. Cycloplegic autorefraction was conducted. The distribution of myopia and pre-myopia was described using frequencies and percentages. The Chi-square test was used to compare the differences in the prevalence of myopia and pre-myopia between regions with different varying economic development levels and between boys and girls, with a significance level of α=0.05.

Results: A total of 12 926 preschool children aged 5-6 years were surveyed. The myopia prevalence was 5.5%, and the overall prevalence of myopia and pre-myopia was 43.4%. Boys had higher rates of myopia and overall prevalence of myopia and pre-myopia than girls (5.7% vs. 5.2%, 46.4% vs. 40.1%), though the difference in myopia prevalence was not statistically significant. Stratified analysis by the province, there was no statistically significant differences in the prevalence of myopia between boys and girls in any province (P>0.05), but in 8 provinces, the prevalence of myopia in boys was slightly higher than in girls. The overall prevalence of myopia and pre-myopia in boys was higher than in girls across all the 10 provinces, with 5 provinces showing statistically significant differences (P < 0.05). The investigated areas were divided into two categories, relatively more-developed areas and relatively less-developed areas, based on per capita gross domestic product (GDP). In 6 provinces, there was no statistically significant difference in the prevalence of myopia between the two categories of areas. In 2 provinces, the prevalence was higher in relatively more-developed areas, and in 2 provinces, it was higher in relatively less-developed areas. In 4 provinces, there was no statistically significant difference in the overall prevalence of myopia and pre-myopia between the two categories of areas with relatively more-developed and relatively less-developed areas. In 3 provinces, the prevalence was higher in relatively more-developed areas, and in 3 provinces, it was higher in relatively less-developed areas.

Conclusion: The prevalence of myopia and pre-myopia among preschool children aged 5-6 years is relatively high. Boys show higher overall prevalence of myopia and pre-myopia than girls, but there is no significant difference in the prevalence of myopia. There is no consistent association between the level of economic development and the incidence of myopia and pre-myopia in each province.

目的:了解中国10个省、市(以下简称省)5 ~ 6岁学龄前儿童近视及准近视患病率,为近视防控及相关卫生资源配置提供参考。方法:采用方便抽样的方法,从全国10个省(8省2市)的21个城市抽取5 ~ 6岁学龄前儿童。进行睫状体麻痹性自屈光检查。用频率和百分比描述近视和准近视的分布。采用卡方检验比较不同经济发展水平地区和男孩、女孩之间近视和准近视患病率的差异,显著性水平为α=0.05。结果:共调查了12 926名5 ~ 6岁学龄前儿童。近视患病率为5.5%,近视和准近视总体患病率为43.4%。男孩的近视率和近视前期总体患病率均高于女孩(5.7%比5.2%,46.4%比40.1%),但近视患病率差异无统计学意义。按省份分层分析,各省份男童、女童近视患病率差异无统计学意义(P < 0.05),但有8个省份男童近视患病率略高于女童。10个省份男童近视和准近视总体患病率均高于女童,其中5个省份差异有统计学意义(P < 0.05)。根据人均国内生产总值(GDP),调查地区分为相对较发达地区和相对欠发达地区两类。在6个省份中,两类地区的近视患病率差异无统计学意义。2个省份中,较发达地区患病率较高,较不发达地区患病率较高。在4个省份中,相对发达地区和相对欠发达地区两类地区的近视和准近视总体患病率差异无统计学意义。3个省份中,相对发达地区患病率较高,相对欠发达地区患病率较高。结论:5 ~ 6岁学龄前儿童近视及准近视患病率较高。男孩的近视和准近视总体患病率高于女孩,但近视患病率无显著差异。各省经济发展水平与近视眼和准近视眼发病率之间没有一致的相关性。
{"title":"[Epidemiological characteristics of myopia and pre-myopia among preschool children aged 5-6 years in ten provinces of China].","authors":"M Tang, Y Liu, R Qin, X Guo, H Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To describe the prevalence of myopia and pre-myopia among preschool children aged 5-6 years in ten provinces or municipalities (hereinafter referred to as province) of China, and to provide a reference for the prevention and control of myopia, and the allocation of related health resources.</p><p><strong>Methods: </strong>Convenience sampling was used to select preschool children aged 5-6 years from 21 cities in 10 provinces (including 8 provinces and 2 municipalities) in China. Cycloplegic autorefraction was conducted. The distribution of myopia and pre-myopia was described using frequencies and percentages. The Chi-square test was used to compare the differences in the prevalence of myopia and pre-myopia between regions with different varying economic development levels and between boys and girls, with a significance level of α=0.05.</p><p><strong>Results: </strong>A total of 12 926 preschool children aged 5-6 years were surveyed. The myopia prevalence was 5.5%, and the overall prevalence of myopia and pre-myopia was 43.4%. Boys had higher rates of myopia and overall prevalence of myopia and pre-myopia than girls (5.7% <i>vs.</i> 5.2%, 46.4% <i>vs.</i> 40.1%), though the difference in myopia prevalence was not statistically significant. Stratified analysis by the province, there was no statistically significant differences in the prevalence of myopia between boys and girls in any province (<i>P</i>>0.05), but in 8 provinces, the prevalence of myopia in boys was slightly higher than in girls. The overall prevalence of myopia and pre-myopia in boys was higher than in girls across all the 10 provinces, with 5 provinces showing statistically significant differences (<i>P</i> < 0.05). The investigated areas were divided into two categories, relatively more-developed areas and relatively less-developed areas, based on per capita gross domestic product (GDP). In 6 provinces, there was no statistically significant difference in the prevalence of myopia between the two categories of areas. In 2 provinces, the prevalence was higher in relatively more-developed areas, and in 2 provinces, it was higher in relatively less-developed areas. In 4 provinces, there was no statistically significant difference in the overall prevalence of myopia and pre-myopia between the two categories of areas with relatively more-developed and relatively less-developed areas. In 3 provinces, the prevalence was higher in relatively more-developed areas, and in 3 provinces, it was higher in relatively less-developed areas.</p><p><strong>Conclusion: </strong>The prevalence of myopia and pre-myopia among preschool children aged 5-6 years is relatively high. Boys show higher overall prevalence of myopia and pre-myopia than girls, but there is no significant difference in the prevalence of myopia. There is no consistent association between the level of economic development and the incidence of myopia and pre-myopia in each province.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"442-447"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Establishment of outcome indicators for the implementation of comprehensive intervention for multimorbidity of myopia and obesity among children and adolescents based on the RE-AIM framework]. [基于RE-AIM框架的儿童青少年近视肥胖多发病综合干预实施结果指标的建立]。
Q3 Medicine Pub Date : 2025-06-18
Y Zhang, S Cai, Z Chen, Y Liu, J Dang, D Shi, J Li, T Huang, Y Song

Objective: To develop outcome indicators for the implementation of comprehensive interventions targeting the multimorbidity of myopia and obesity in children and adolescents, providing a basis for the co-prevention of multimorbidity and the outcome measurement of implementation research in children and adolescents.

Methods: Based on the RE-AIM framework, a preliminary set of indicators was constructed. The Delphi method was employed, with experts scoring and providing feedback on the proposed indicators via questionnaires. After each round of consultation, expert enthusiasm index, authority coefficient, coordination degree, and consensus level were calculated. Expert opinions were collected and analyzed to modify, delete, or add indicators based on consultation results and screening criteria. Two Delphi rounds were conducted until consensus was achieved.

Results: A total of 28 experts participated actually in both rounds. The Kendall' s W coefficients for the two rounds of expert consultation were 0.352 (χ2=413.952, P < 0.001) and 0.499 (χ2=405.044, P < 0.001), both statistically significant. The final outcome indicators for implementation research on comprehensive interventions for myopia and obesity comorbidity in children and adolescents included five primary dimensions with 13 secondary and 20 tertiary indicators. The dimension of reach included the number of children and adolescents involved, participant representativeness, and full-course participation representativeness. The dimension of effectiveness included multimorbidity incidence, myopia incidence, spherical equivalent, body mass index (BMI), overweight and obesity prevalence, waist-to-height ratio, comprehensive health knowledge score, and comprehensive health behavior score. The dimension of adoption covered school representativeness and representativeness of school nurses and teachers involved in implementation. The dimension of implementation included fidelity, content modification, and cost. The dimension of maintenance included individual health outcomes and organizational sustainment.

Conclusion: This study developed implementation outcome indicators for comprehensive interventions targeting multimorbidity of myopia and obesity among the children and adolescents based on the RE-AIM framework. These indicators can serve as a reference for optimizing intervention research strategies related to common multimorbidity among children and adolescents in China.

目的:制定针对儿童青少年近视和肥胖多发病综合干预措施实施的结局指标,为儿童青少年多发病联合预防及实施研究的结局测量提供依据。方法:基于RE-AIM框架,构建一套初步指标体系。采用德尔菲法,由专家通过问卷对提出的指标进行评分和反馈。每轮咨询结束后,计算专家热情指数、权威系数、协调度、共识度。收集和分析专家意见,根据咨询结果和筛选标准修改、删除或增加指标。在达成协商一致意见之前,进行了两轮德尔菲会议。结果:两轮实际参与专家共计28人。两轮专家咨询的Kendall’s W系数分别为0.352 (χ2=413.952, P < 0.001)和0.499 (χ2=405.044, P < 0.001),均有统计学意义。儿童青少年近视和肥胖合并症综合干预实施研究的最终结果指标包括5个一级维度,13个二级指标和20个三级指标。到达性维度包括参与儿童和青少年人数、参与者代表性、全程参与代表性。效度维度包括多病发生率、近视发生率、球形当量、体重指数(BMI)、超重和肥胖患病率、腰高比、综合健康知识评分和综合健康行为评分。采用的维度包括学校代表性和参与实施的学校护士和教师的代表性。实现的维度包括保真度、内容修改和成本。维持维度包括个人健康结果和组织维持。结论:本研究基于RE-AIM框架,制定了针对儿童青少年多发病近视和肥胖的综合干预实施结果指标。这些指标可为优化中国儿童青少年常见多发病相关的干预研究策略提供参考。
{"title":"[Establishment of outcome indicators for the implementation of comprehensive intervention for multimorbidity of myopia and obesity among children and adolescents based on the RE-AIM framework].","authors":"Y Zhang, S Cai, Z Chen, Y Liu, J Dang, D Shi, J Li, T Huang, Y Song","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To develop outcome indicators for the implementation of comprehensive interventions targeting the multimorbidity of myopia and obesity in children and adolescents, providing a basis for the co-prevention of multimorbidity and the outcome measurement of implementation research in children and adolescents.</p><p><strong>Methods: </strong>Based on the RE-AIM framework, a preliminary set of indicators was constructed. The Delphi method was employed, with experts scoring and providing feedback on the proposed indicators <i>via</i> questionnaires. After each round of consultation, expert enthusiasm index, authority coefficient, coordination degree, and consensus level were calculated. Expert opinions were collected and analyzed to modify, delete, or add indicators based on consultation results and screening criteria. Two Delphi rounds were conducted until consensus was achieved.</p><p><strong>Results: </strong>A total of 28 experts participated actually in both rounds. The Kendall' s <i>W</i> coefficients for the two rounds of expert consultation were 0.352 (<i>χ</i><sup>2</sup>=413.952, <i>P</i> < 0.001) and 0.499 (<i>χ</i><sup>2</sup>=405.044, <i>P</i> < 0.001), both statistically significant. The final outcome indicators for implementation research on comprehensive interventions for myopia and obesity comorbidity in children and adolescents included five primary dimensions with 13 secondary and 20 tertiary indicators. The dimension of reach included the number of children and adolescents involved, participant representativeness, and full-course participation representativeness. The dimension of effectiveness included multimorbidity incidence, myopia incidence, spherical equivalent, body mass index (BMI), overweight and obesity prevalence, waist-to-height ratio, comprehensive health knowledge score, and comprehensive health behavior score. The dimension of adoption covered school representativeness and representativeness of school nurses and teachers involved in implementation. The dimension of implementation included fidelity, content modification, and cost. The dimension of maintenance included individual health outcomes and organizational sustainment.</p><p><strong>Conclusion: </strong>This study developed implementation outcome indicators for comprehensive interventions targeting multimorbidity of myopia and obesity among the children and adolescents based on the RE-AIM framework. These indicators can serve as a reference for optimizing intervention research strategies related to common multimorbidity among children and adolescents in China.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"436-441"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A randomized controlled trial of weight management based on mobile health techno-logy among overweight or obese pregnant women]. [基于移动医疗技术的超重或肥胖孕妇体重管理的随机对照试验]。
Q3 Medicine Pub Date : 2025-06-18
P Li, H Wang, X Gao, Y Han, H Wang, H Wang, Y Mu
<p><strong>Objective: </strong>To evaluate the effect of lifestyle interventions based on mobile health technology on gestational weight gain among overweight or obese pregnant women, to explore the influencing factors of the intervention effect, and to provide scientific evidence for weight management during pregnancy.</p><p><strong>Methods: </strong>The randomized controlled trial (RCT) design was used. From April 2024 to August 2024, 200 singleton overweight or obese pregnant women aged 18-40 years in early pregnancy were recruited and stratified block-randomized according to body mass index (BMI) categories, age, and parity. The control group received routine prenatal care, while the intervention group received lifestyle interventions based on mobile health technology, which included biweekly face-to-face or telephone sessions; weekly recording of dietary behavior goals with personalized feedback on WeChat public account; 6 000 steps per day and 150 minutes of brisk walking per week; and weekly weight recording with personalized feedback. Based on the intention-to-treat principle, generalized linear mixed models were used to analyze the effects on weight gain and weight gain rate up to 24-28 gestational weeks, gestational diabetes mellitus (GDM), and dietary and physical activity behaviors. Additionally, subgroup analysis and interaction analysis were conducted to explore whether intervention effects on weight gain varied by different maternal characteristics.</p><p><strong>Results: </strong>The mean age of the women in the intervention and control groups was (30.49± 3.99) years and (29.83±3.95) years, respectively, with gestational weeks at enrollment being (11.35±1.61) weeks and (11.26±1.52) weeks. No statistically significant differences were observed in the baseline characteristics between the two groups (<i>P</i>>0.05). In the study, 10 and 12 participants were lost to the follow-up in the intervention and control groups, respectively, with 178 women completing the midterm follow-up. At the midterm follow-up (24-28 weeks), the weight gain in the intervention and control groups was (5.00±3.72) kg and (6.57±4.28) kg, respectively. After adjusting for age, parity, gravidity, region, pre-pregnancy BMI categories, and socioeconomic status, the between-group difference was -1.63 kg (95%<i>CI</i>: -2.80 to -0.46; <i>P</i>=0.007). The adjusted between-group difference in weight gain rate was -0.07 kg/week (95%<i>CI</i>: -0.11 to -0.02; <i>P</i>=0.005). Compared with the control group, the intervention group had lower fasting blood glucose at the oral glucose tolerance test (OGTT) by 0.19 mmol/L (95%<i>CI</i>: 0.04 to 0.33; <i>P</i>=0.013). No significant difference was observed in GDM incidence between the two groups. Among different subgroups based on characteristics, such as age, region, socioeconomic status, and parity, there was no statistically significant dif-ference in the effect on weight gain.</p><p><strong>Conclusion: </strong>The life
目的:评价基于移动健康技术的生活方式干预对超重或肥胖孕妇妊娠期体重增加的影响,探讨干预效果的影响因素,为孕期体重管理提供科学依据。方法:采用随机对照试验(RCT)设计。从2024年4月到2024年8月,招募了200名年龄在18-40岁的单胎超重或肥胖早孕孕妇,并根据体重指数(BMI)类别、年龄和胎次进行分层块随机化。对照组接受常规产前护理,干预组接受基于移动医疗技术的生活方式干预,包括每两周一次的面对面或电话会议;每周记录饮食行为目标并在微信公众号进行个性化反馈;每天6 000步,每周快走150分钟;每周记录体重,并提供个性化反馈。基于意向-治疗原则,采用广义线性混合模型分析妊娠24-28周体重增加和增重率、妊娠期糖尿病(GDM)、饮食和身体活动行为的影响。此外,通过亚组分析和相互作用分析,探讨干预对体重增加的影响是否因产妇特征不同而不同。结果:干预组和对照组妇女的平均年龄分别为(30.49±3.99)岁和(29.83±3.95)岁,入组时妊娠周分别为(11.35±1.61)周和(11.26±1.52)周。两组患者基线特征比较,差异无统计学意义(P < 0.05)。在这项研究中,干预组和对照组分别有10名和12名参与者失去了随访,其中178名女性完成了中期随访。中期随访(24-28周)时,干预组和对照组体重增加分别为(5.00±3.72)kg和(6.57±4.28)kg。在调整了年龄、胎次、妊娠、地区、孕前BMI类别和社会经济地位后,组间差异为-1.63 kg (95%CI: -2.80 ~ -0.46;P = 0.007)。体重增加率调整后的组间差异为-0.07 kg/周(95%CI: -0.11 ~ -0.02;P = 0.005)。与对照组相比,干预组口服糖耐量试验(OGTT)空腹血糖降低0.19 mmol/L (95%CI: 0.04 ~ 0.33;P = 0.013)。两组间GDM发病率无显著差异。在基于年龄、地区、社会经济地位和性别等特征的不同亚组中,对体重增加的影响没有统计学上的显著差异。结论:基于移动健康技术的生活方式干预可有效控制超重或肥胖妇女24-28孕周体重增加,改善空腹血糖水平。这对改善中国超重或肥胖孕妇的健康具有重要的公共卫生意义。
{"title":"[A randomized controlled trial of weight management based on mobile health techno-logy among overweight or obese pregnant women].","authors":"P Li, H Wang, X Gao, Y Han, H Wang, H Wang, Y Mu","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the effect of lifestyle interventions based on mobile health technology on gestational weight gain among overweight or obese pregnant women, to explore the influencing factors of the intervention effect, and to provide scientific evidence for weight management during pregnancy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The randomized controlled trial (RCT) design was used. From April 2024 to August 2024, 200 singleton overweight or obese pregnant women aged 18-40 years in early pregnancy were recruited and stratified block-randomized according to body mass index (BMI) categories, age, and parity. The control group received routine prenatal care, while the intervention group received lifestyle interventions based on mobile health technology, which included biweekly face-to-face or telephone sessions; weekly recording of dietary behavior goals with personalized feedback on WeChat public account; 6 000 steps per day and 150 minutes of brisk walking per week; and weekly weight recording with personalized feedback. Based on the intention-to-treat principle, generalized linear mixed models were used to analyze the effects on weight gain and weight gain rate up to 24-28 gestational weeks, gestational diabetes mellitus (GDM), and dietary and physical activity behaviors. Additionally, subgroup analysis and interaction analysis were conducted to explore whether intervention effects on weight gain varied by different maternal characteristics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The mean age of the women in the intervention and control groups was (30.49± 3.99) years and (29.83±3.95) years, respectively, with gestational weeks at enrollment being (11.35±1.61) weeks and (11.26±1.52) weeks. No statistically significant differences were observed in the baseline characteristics between the two groups (&lt;i&gt;P&lt;/i&gt;&gt;0.05). In the study, 10 and 12 participants were lost to the follow-up in the intervention and control groups, respectively, with 178 women completing the midterm follow-up. At the midterm follow-up (24-28 weeks), the weight gain in the intervention and control groups was (5.00±3.72) kg and (6.57±4.28) kg, respectively. After adjusting for age, parity, gravidity, region, pre-pregnancy BMI categories, and socioeconomic status, the between-group difference was -1.63 kg (95%&lt;i&gt;CI&lt;/i&gt;: -2.80 to -0.46; &lt;i&gt;P&lt;/i&gt;=0.007). The adjusted between-group difference in weight gain rate was -0.07 kg/week (95%&lt;i&gt;CI&lt;/i&gt;: -0.11 to -0.02; &lt;i&gt;P&lt;/i&gt;=0.005). Compared with the control group, the intervention group had lower fasting blood glucose at the oral glucose tolerance test (OGTT) by 0.19 mmol/L (95%&lt;i&gt;CI&lt;/i&gt;: 0.04 to 0.33; &lt;i&gt;P&lt;/i&gt;=0.013). No significant difference was observed in GDM incidence between the two groups. Among different subgroups based on characteristics, such as age, region, socioeconomic status, and parity, there was no statistically significant dif-ference in the effect on weight gain.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The life","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"465-472"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ipsilateral femoral neck fracture after fixation of intertrochanteric fracture by InterTAN intramedullary nail: A case report]. InterTAN髓内钉固定股骨粗隆间骨折后发生同侧股骨颈骨折1例。
Q3 Medicine Pub Date : 2025-06-18
T Ning, L Pan, Y Ye, Y Cao

Hip fractures are common in elderly patients and are associated with significant morbidity and mortality, often referred to as the "last fracture of life". These fractures frequently result in a loss of functional independence. Evidence suggests that early surgical intervention can reduce mortality. The selection of treatment modality should take into account factors such as the type of fracture, the patient' s age, and overall health status. This case report discusses an 88-year-old female patient who sustained an unstable intertrochanteric fracture of the left femur following a fall. She underwent closed reduction and internal fixation using an InterTAN intramedullary nail, resulting in a satisfactory postoperative recovery. Sixteen months following the surgical procedure, the patient presented with progressive pain in the left hip and ambulatory difficulties, absent from any evident trauma. Radiographic analysis identified a fracture of the left femoral neck accompanied by some degree of acetabular bone degradation attributable to the implant. Subsequently, the patient underwent removal of the internal fixation device and received a hemiarthroplasty. The postoperative course was uneventful, with marked improvements in both pain levels and functional capacity. This case underscored the intricate nature of femoral neck fractures following the internal fixation of intertrochanteric fractures. Contributing factors may include advanced age, osteoporosis, and stress shielding induced by the implant. In patients presenting with hip pain or gait disturbances months to years post-intertrochanteric fracture surgery, the potential for a new fracture should be consi- dered, even in the absence of an explicit traumatic incident. Radiographic imaging is imperative to exclude the presence of a fracture, particularly in individuals with high-risk factors such as advanced age, osteoporosis, alcohol abuse, and a history of hormone therapy. Management of such cases may necessitate the removal of internal fixation devices and the implementation of hemiarthroplasty or total hip arthroplasty, contingent upon the patient ' s surgical tolerance. Crucially, anti-osteoporosis therapy serves as a vital preventive strategy. Considering the high-risk profile of elderly patients with hip fractures, diligent follow-up and timely intervention are paramount to mitigating complications and mortality, thereby enhancing the quality of life for these patients. This case highlights the critical need for increased vigilance and comprehensive management of elderly patients with hip fractures to enhance treatment outcomes and improve prognosis.

髋部骨折在老年患者中很常见,并与显著的发病率和死亡率相关,通常被称为“生命中的最后一次骨折”。这些骨折经常导致功能独立性的丧失。有证据表明,早期手术干预可以降低死亡率。治疗方式的选择应考虑骨折类型、患者年龄和整体健康状况等因素。本病例报告讨论了一位88岁的女性患者,她在跌倒后持续发生不稳定的左股骨粗隆间骨折。患者采用InterTAN髓内钉进行闭合复位和内固定,术后恢复良好。手术后16个月,患者出现左髋关节进行性疼痛和行动困难,无明显外伤。x线分析发现左股骨颈骨折伴一定程度的髋臼骨退化,可归因于植入物。随后,患者取出内固定装置并接受半关节置换术。术后过程顺利,疼痛水平和功能能力均有明显改善。本病例强调股骨粗隆间骨折内固定后股骨颈骨折的复杂性。影响因素可能包括高龄、骨质疏松和由种植体引起的应力屏蔽。对于股骨粗隆间骨折术后数月至数年出现髋关节疼痛或步态障碍的患者,即使没有明确的创伤事件,也应考虑发生新骨折的可能性。影像学检查对于排除骨折的存在是必要的,特别是对于具有高龄、骨质疏松、酗酒和激素治疗史等高危因素的个体。此类病例的处理可能需要移除内固定装置并实施半髋关节置换术或全髋关节置换术,这取决于患者的手术耐受性。至关重要的是,抗骨质疏松治疗是一种重要的预防策略。考虑到老年髋部骨折患者的高危特点,积极的随访和及时的干预对减轻并发症和死亡率至关重要,从而提高患者的生活质量。本病例强调了对老年髋部骨折患者提高警惕和综合管理的迫切需要,以提高治疗效果和改善预后。
{"title":"[Ipsilateral femoral neck fracture after fixation of intertrochanteric fracture by InterTAN intramedullary nail: A case report].","authors":"T Ning, L Pan, Y Ye, Y Cao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hip fractures are common in elderly patients and are associated with significant morbidity and mortality, often referred to as the \"last fracture of life\". These fractures frequently result in a loss of functional independence. Evidence suggests that early surgical intervention can reduce mortality. The selection of treatment modality should take into account factors such as the type of fracture, the patient' s age, and overall health status. This case report discusses an 88-year-old female patient who sustained an unstable intertrochanteric fracture of the left femur following a fall. She underwent closed reduction and internal fixation using an InterTAN intramedullary nail, resulting in a satisfactory postoperative recovery. Sixteen months following the surgical procedure, the patient presented with progressive pain in the left hip and ambulatory difficulties, absent from any evident trauma. Radiographic analysis identified a fracture of the left femoral neck accompanied by some degree of acetabular bone degradation attributable to the implant. Subsequently, the patient underwent removal of the internal fixation device and received a hemiarthroplasty. The postoperative course was uneventful, with marked improvements in both pain levels and functional capacity. This case underscored the intricate nature of femoral neck fractures following the internal fixation of intertrochanteric fractures. Contributing factors may include advanced age, osteoporosis, and stress shielding induced by the implant. In patients presenting with hip pain or gait disturbances months to years post-intertrochanteric fracture surgery, the potential for a new fracture should be consi- dered, even in the absence of an explicit traumatic incident. Radiographic imaging is imperative to exclude the presence of a fracture, particularly in individuals with high-risk factors such as advanced age, osteoporosis, alcohol abuse, and a history of hormone therapy. Management of such cases may necessitate the removal of internal fixation devices and the implementation of hemiarthroplasty or total hip arthroplasty, contingent upon the patient ' s surgical tolerance. Crucially, anti-osteoporosis therapy serves as a vital preventive strategy. Considering the high-risk profile of elderly patients with hip fractures, diligent follow-up and timely intervention are paramount to mitigating complications and mortality, thereby enhancing the quality of life for these patients. This case highlights the critical need for increased vigilance and comprehensive management of elderly patients with hip fractures to enhance treatment outcomes and improve prognosis.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"610-613"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological investigation of asthenopia and dry eye among visual display terminal workers]. 视觉显示终端工作人员弱视、干眼的流行病学调查。
Q3 Medicine Pub Date : 2025-06-18
L Yang, X Jin, W Huang, L He, J Chen

Objective: To investigate the prevalence of asthenopia and dry eye, and to further explore the potential occupational hazard factors, so as to provide a theoretical basis for their prevention and control.

Methods: A cross-sectional survey was conducted on the selected respondents. For visual display terminal (VDT) workers in employing organizations such as banks, colleges, and government departments, an online questionnaire independently developed by the research group was used for population surveys. Information including general information, work-related situations, work environment, visual health, and ergonomic factors was collected. The respondents were analyzed according to whether they suffered from asthenopia and dry eye. Relevant factors of asthenopia and dry eye were screened through t-test and Chi-square test. Subsequently, binary Logistic regression analysis was carried out to determine the risk factors of asthenopia and dry eye among the VDT workers.

Results: The overall prevalence of asthenopia was 52.5% (235/448) and dry eye was 36.8% (165/448). There were no significant diffe-rences in the prevalence of asthenopia and dry eye among different genders, age groups, and groups of length of service in VDT work. However, the highest prevalence of dry eye was observed in underweight individuals (42.9%), followed by normal weight (40.6%), overweight (28.0%), and obese indivi-duals (17.4%). There was a significant difference in the prevalence of dry eye among different body mass index (BMI) groups (χ2=9.505, P=0.023). The lowest prevalence of asthenopia was observed among securities industry employees (22.6%), while higher rates were found in employees in companies (59.5%) and other employing organizations (68.8%). A significant difference in the prevalence of asthenopia among different employing organizations (χ2=14.832, P=0.022). The result of Logistic regression showed that a longer length of service in VDT work (OR=1.006, P < 0.001), a longer duration of VDT after working hours (OR=1.002, P=0.032), a too-bright monitor (OR=2.875, P=0.022), glare during work (OR=1.500, P=0.038), a louder noise in work environment (OR=1.586, P=0.012), work-related musculoskeletal disorders (WMSDs) (OR=4.366, P < 0.001) and other factors were independent risk factors of asthenopia, while wearing frame glasses (OR=0.452, P=0.037) was an independent protective factor. Glare during work (OR=2.198, P < 0.001), WMSDs (OR=2.226, P=0.001) and other factors were independent risk factors of dry eye, while overweight (OR=0.448, P=0.006), obesity (OR=0.228, P=0.032) were independent protective factors of dry eye.

Conclusion: The prevalence of asthenopia and dry eye among V

目的:调查老年人视疲劳和干眼的患病率,进一步探讨其潜在的职业危害因素,为其防治提供理论依据。方法:采用横断面调查法对所选对象进行调查。针对银行、高校、政府部门等用人单位的可视显示终端(VDT)从业人员,采用课题组自主开发的在线问卷进行人口调查。收集的信息包括一般信息、与工作有关的情况、工作环境、视觉健康和人体工程学因素。根据受访者是否患有视疲劳和干眼症进行分析。通过t检验和卡方检验筛选弱视和干眼的相关因素。随后,进行二元Logistic回归分析,以确定VDT工人弱视和干眼的危险因素。结果:总视弱视患病率为52.5%(235/448),干眼患病率为36.8%(165/448)。不同性别、不同年龄、不同工龄的视障人员视弱视和干眼的患病率差异无统计学意义。然而,干眼症患病率最高的是体重过轻者(42.9%),其次是正常体重者(40.6%)、超重者(28.0%)和肥胖者(17.4%)。不同体重指数(BMI)组间干眼症患病率差异有统计学意义(χ2=9.505, P=0.023)。视疲劳率最低的是证券行业(22.6%),其次是企业(59.5%)和其他用人单位(68.8%)。不同用人单位的视弱视患病率差异有统计学意义(χ2=14.832, P=0.022)。Logistic回归结果显示,VDT工作时间较长(OR=1.006, P < 0.001)、工作时间后VDT持续时间较长(OR=1.002, P=0.032)、显示器过亮(OR=2.875, P=0.022)、工作时眩光(OR=1.500, P=0.038)、工作环境噪声较大(OR=1.586, P=0.012)、与工作相关的肌肉骨骼疾病(OR=4.366, P < 0.001)等因素是近视的独立危险因素,而佩戴框架眼镜(OR=0.452, P=0.032)、P=0.037)是独立的保护因素。工作时眩光(OR=2.198, P < 0.001)、WMSDs (OR=2.226, P=0.001)等因素是干眼症的独立危险因素,而超重(OR=0.448, P=0.006)、肥胖(OR=0.228, P=0.032)是干眼症的独立保护因素。结论:VDT作业人员视疲劳、干眼患病率较高,且与多种危险因素有关。在防治过程中,应注意工作时合理休息,控制眩光,加强视觉健康培训和宣传。
{"title":"[Epidemiological investigation of asthenopia and dry eye among visual display terminal workers].","authors":"L Yang, X Jin, W Huang, L He, J Chen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the prevalence of asthenopia and dry eye, and to further explore the potential occupational hazard factors, so as to provide a theoretical basis for their prevention and control.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted on the selected respondents. For visual display terminal (VDT) workers in employing organizations such as banks, colleges, and government departments, an online questionnaire independently developed by the research group was used for population surveys. Information including general information, work-related situations, work environment, visual health, and ergonomic factors was collected. The respondents were analyzed according to whether they suffered from asthenopia and dry eye. Relevant factors of asthenopia and dry eye were screened through <i>t</i>-test and Chi-square test. Subsequently, binary Logistic regression analysis was carried out to determine the risk factors of asthenopia and dry eye among the VDT workers.</p><p><strong>Results: </strong>The overall prevalence of asthenopia was 52.5% (235/448) and dry eye was 36.8% (165/448). There were no significant diffe-rences in the prevalence of asthenopia and dry eye among different genders, age groups, and groups of length of service in VDT work. However, the highest prevalence of dry eye was observed in underweight individuals (42.9%), followed by normal weight (40.6%), overweight (28.0%), and obese indivi-duals (17.4%). There was a significant difference in the prevalence of dry eye among different body mass index (BMI) groups (<i>χ</i><sup>2</sup>=9.505, <i>P</i>=0.023). The lowest prevalence of asthenopia was observed among securities industry employees (22.6%), while higher rates were found in employees in companies (59.5%) and other employing organizations (68.8%). A significant difference in the prevalence of asthenopia among different employing organizations (<i>χ</i><sup>2</sup>=14.832, <i>P</i>=0.022). The result of Logistic regression showed that a longer length of service in VDT work (<i>OR</i>=1.006, <i>P</i> < 0.001), a longer duration of VDT after working hours (<i>OR</i>=1.002, <i>P</i>=0.032), a too-bright monitor (<i>OR</i>=2.875, <i>P</i>=0.022), glare during work (<i>OR</i>=1.500, <i>P</i>=0.038), a louder noise in work environment (<i>OR</i>=1.586, <i>P</i>=0.012), work-related musculoskeletal disorders (WMSDs) (<i>OR</i>=4.366, <i>P</i> < 0.001) and other factors were independent risk factors of asthenopia, while wearing frame glasses (<i>OR</i>=0.452, <i>P</i>=0.037) was an independent protective factor. Glare during work (<i>OR</i>=2.198, <i>P</i> < 0.001), WMSDs (<i>OR</i>=2.226, <i>P</i>=0.001) and other factors were independent risk factors of dry eye, while overweight (<i>OR</i>=0.448, <i>P</i>=0.006), obesity (<i>OR</i>=0.228, <i>P</i>=0.032) were independent protective factors of dry eye.</p><p><strong>Conclusion: </strong>The prevalence of asthenopia and dry eye among V","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"554-561"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Challenges and prospects of the application of the amendments to the International Health Regulations (2005) in China]. [《国际卫生条例(2005)》修正案在中国适用的挑战和前景]。
Q3 Medicine Pub Date : 2025-06-18
L Chen, M Ren

With the increasingly complex global health and safety situation, in order to establish a strong global health and safety governance system, promote international cooperation and ensure public health and safety, the member countries of the World Health Organization initiated the revision of the International Health Regulations (2005). After the amendment of the International Health Regulations (2005) was adopted on 1 June 2024, China, as one of the contracting parties, urgently needs to promote the domestic rule of law and the foreign-related rule of law as a whole, realise the effective connection between domestic law and this regulation, and promote the transformation and application of international law. Compared with the original regulations, the Amendment has adjusted and improved relevant health measures, strengthened the construction of the public health service system, and further clarified the responsibilities and obligations of both the World Health Organization and the Parties, which has led to the application of the amendment to the International Health Regulations (2005) in China. Therefore, it is necessary to improve the domestic health law and regulation system, strengthen domestic core capacity building, deepen international cooperation and promote global governance, and strive to promote the solution of these problems.

随着全球卫生安全形势日益复杂,为建立强有力的全球卫生安全治理体系,促进国际合作,保障公共卫生安全,世界卫生组织成员国启动了《国际卫生条例(2005)》修订工作。《国际卫生条例(2005)》修正案于2024年6月1日通过后,中国作为缔约国之一,迫切需要从整体上推进国内法治和涉外法治,实现国内法与该条例的有效衔接,促进国际法的转化和适用。与原条例相比,该修正案调整和完善了相关卫生措施,加强了公共卫生服务体系建设,进一步明确了世界卫生组织和缔约方的责任和义务,促进了《国际卫生条例(2005)》在中国的适用。因此,有必要完善国内卫生法律法规体系,加强国内核心能力建设,深化国际合作,推进全球治理,努力推动这些问题的解决。
{"title":"[Challenges and prospects of the application of the amendments to the <i>International Health Regulations</i> (<i>2005</i>) in China].","authors":"L Chen, M Ren","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>With the increasingly complex global health and safety situation, in order to establish a strong global health and safety governance system, promote international cooperation and ensure public health and safety, the member countries of the World Health Organization initiated the revision of the <i>International Health Regulations</i> (<i>2005</i>). After the amendment of the <i>International Health Regulations</i> (<i>2005</i>) was adopted on 1 June 2024, China, as one of the contracting parties, urgently needs to promote the domestic rule of law and the foreign-related rule of law as a whole, realise the effective connection between domestic law and this regulation, and promote the transformation and application of international law. Compared with the original regulations, the Amendment has adjusted and improved relevant health measures, strengthened the construction of the public health service system, and further clarified the responsibilities and obligations of both the World Health Organization and the Parties, which has led to the application of the amendment to the <i>International Health Regulations</i> (<i>2005</i>) in China. Therefore, it is necessary to improve the domestic health law and regulation system, strengthen domestic core capacity building, deepen international cooperation and promote global governance, and strive to promote the solution of these problems.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"411-416"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological characteristics of febrile seizure among children under 6 years old in Ningbo City from 2015 to 2021]. 宁波市2015 - 2021年6岁以下儿童热性惊厥流行病学特征分析
Q3 Medicine Pub Date : 2025-06-18
G Liu, L Zhang, H Zhao, S Deng, J Yang, N Li, R Ma, Y He, G Xu, Z Liu, S Zhan

Objective: To describe the epidemiological characteristics and changes of febrile seizure (FS) among children under 6 years old in Ningbo City, Zhejiang Province from 2015 to 2021.

Methods: Based on the Ningbo Regional Health Information Platform, a dynamic cohort was established using vaccination registration information, and the cases of FS were identified by the diagnostic results of Chinese terms or International Classification of Diseases 10th revision (ICD-10) R56.0 code in the electronic medical records. The first visit of FS during the observation period was defined as a new case, and a recurrence case was defined as the case with a visit interval of more than 7 days. The 95% confidence interval (CI) of FS incidence density was calculated by the Poisson distribution.

Results: From January 2015 to June 2020, there were 1.3 million children under 6 years old in Ningbo, with male accounting for 52.87%. The median follow-up time was 2.83 (1.55-4.00) years. During the follow-up period, 12 776 new onset cases had FS, with more males than females, with an overall incidence density of 4.34 (95%CI 4.27-4.40)/1 000 person-years and a recurrence rate of 21.63%. There was a higher incidence density in children who were male, born in Ningbo and of non-mobility. The incidence density of FS was higher in urban areas than in rural and rural-urban fringe areas, and the incidence density was different among districts and counties. The peak density was found in children aged 18-23 months [8.42 (95%CI 8.11-8.74)/1 000 person-years]. From 2015 to 2019, the incidence density increased with calendar year (Ptrend < 0.001), and the highest was 5.62 (95%CI 5.43-5.81) /1 000 person-years. The incidence density of FS decreased significantly during the period between 2020 and 2021. The incidence density was higher in winter.

Conclusion: From 2015 to 2019, the overall incidence density of FS in children under 6 years old in Ningbo City presented an increasing trend. More attention should be paid to the health education, the improvement of the health maintenance model, the enhancement of the cognition of FS, the identification and treatment of FS among high-risk population and regions so as to prevent its recurrence and reduce the disease burden during the corona virus disease 2019 (COVID-19) epide-mic.

目的:了解浙江省宁波市2015 - 2021年6岁以下儿童发热性惊厥(FS)的流行病学特征及变化。方法:基于宁波市区域卫生信息平台,利用疫苗接种登记信息建立动态队列,利用电子病历中中文术语或《国际疾病分类第10版》(ICD-10) R56.0代码的诊断结果对FS病例进行识别。观察期内首次就诊FS定义为新病例,就诊间隔大于7天定义为复发病例。采用泊松分布计算FS发生率密度的95%置信区间(CI)。结果:2015年1月至2020年6月,宁波市6岁以下儿童130万人,其中男性占52.87%。中位随访时间为2.83(1.55-4.00)年。随访期间新发FS 12 776例,男性多于女性,总发病率密度为4.34 (95%CI 4.27 ~ 4.40)/ 1000人年,复发率为21.63%。男性、宁波市出生、非流动人群的发病密度较高。FS发病密度在城市地区高于农村和城乡结合部,区县发病密度存在差异。18-23月龄儿童密度最高[8.42 (95%CI 8.11-8.74)/ 1000人年]。2015 - 2019年发病密度随历年增高(p趋势< 0.001),最高为5.62例(95%CI 5.43 ~ 5.81) / 1000人年。2020 - 2021年FS发病密度显著下降。发病率密度在冬季较高。结论:2015 - 2019年宁波市6岁以下儿童FS总体发病密度呈上升趋势。在2019冠状病毒病(COVID-19)流行期间,应加强健康教育,完善健康维护模式,提高对FS的认识,识别和治疗高危人群和地区的FS,以防止其复发,减轻疾病负担。
{"title":"[Epidemiological characteristics of febrile seizure among children under 6 years old in Ningbo City from 2015 to 2021].","authors":"G Liu, L Zhang, H Zhao, S Deng, J Yang, N Li, R Ma, Y He, G Xu, Z Liu, S Zhan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To describe the epidemiological characteristics and changes of febrile seizure (FS) among children under 6 years old in Ningbo City, Zhejiang Province from 2015 to 2021.</p><p><strong>Methods: </strong>Based on the Ningbo Regional Health Information Platform, a dynamic cohort was established using vaccination registration information, and the cases of FS were identified by the diagnostic results of Chinese terms or International Classification of Diseases 10th revision (ICD-10) R56.0 code in the electronic medical records. The first visit of FS during the observation period was defined as a new case, and a recurrence case was defined as the case with a visit interval of more than 7 days. The 95% confidence interval (<i>CI</i>) of FS incidence density was calculated by the Poisson distribution.</p><p><strong>Results: </strong>From January 2015 to June 2020, there were 1.3 million children under 6 years old in Ningbo, with male accounting for 52.87%. The median follow-up time was 2.83 (1.55-4.00) years. During the follow-up period, 12 776 new onset cases had FS, with more males than females, with an overall incidence density of 4.34 (95%<i>CI</i> 4.27-4.40)/1 000 person-years and a recurrence rate of 21.63%. There was a higher incidence density in children who were male, born in Ningbo and of non-mobility. The incidence density of FS was higher in urban areas than in rural and rural-urban fringe areas, and the incidence density was different among districts and counties. The peak density was found in children aged 18-23 months [8.42 (95%<i>CI</i> 8.11-8.74)/1 000 person-years]. From 2015 to 2019, the incidence density increased with calendar year (<i>P</i><sub>trend</sub> < 0.001), and the highest was 5.62 (95%<i>CI</i> 5.43-5.81) /1 000 person-years. The incidence density of FS decreased significantly during the period between 2020 and 2021. The incidence density was higher in winter.</p><p><strong>Conclusion: </strong>From 2015 to 2019, the overall incidence density of FS in children under 6 years old in Ningbo City presented an increasing trend. More attention should be paid to the health education, the improvement of the health maintenance model, the enhancement of the cognition of FS, the identification and treatment of FS among high-risk population and regions so as to prevent its recurrence and reduce the disease burden during the corona virus disease 2019 (COVID-19) epide-mic.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 3","pages":"584-591"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
北京大学学报(医学版)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1